<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01256138</url>
  </required_header>
  <id_info>
    <org_study_id>SunYat-sen U 11-5-2</org_study_id>
    <nct_id>NCT01256138</nct_id>
  </id_info>
  <brief_title>Allogene MSCs Transplantation in Liver for Patients With Chronic Liver Diseases Through Portal Vein by Ultrasound Guiding</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Allogene MSCs transplantation will be performed in patients with chronic liver diseases
      through portal vein by ultrasound guiding and therapeutic effects including short-term
      effects and long-term follow-up will be compared and investigated.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Short-term therapeutic effects at 1-8 weeks after Allogene MSCs transplantation</measure>
    <time_frame>1-8 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Allogene Transplantation</condition>
  <condition>Chronic Liver Diseases Patients</condition>
  <condition>Through Portal Vein by Ultrasound Guiding</condition>
  <arm_group>
    <arm_group_label>transplantation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic liver diseases including: viral hepatitis, alcoholic liver disease,
        autoimmune liver disease and so on.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. chronic liver diseases including: viral hepatitis, alcoholic liver disease, autoimmune
             liver disease.

          2. age: 15-65 years old.

        Exclusion Criteria:

          1. pregnant women and women in lactation.

          2. other systems and organs disfunction

          3. space-occupying lesion were found in liver.

          4. concurrent infection with HIV and other immunodeficiency diseases.

          5. DIC and active bleeding were confirmed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Infectious Diseases, 3rd Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liang Peng, Dr.</last_name>
      <phone>+86-013533978874</phone>
      <email>pzp33@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jing Liu, Master.</last_name>
      <phone>+86-013556051920</phone>
      <email>diudiu1203@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2010</study_first_submitted>
  <study_first_submitted_qc>December 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2010</study_first_posted>
  <last_update_submitted>December 7, 2010</last_update_submitted>
  <last_update_submitted_qc>December 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Zhi-liang Gao</name_title>
    <organization>Department of Infectious Diseases, 3rd Affiliated Hospital of Sun Yat-sen University</organization>
  </responsible_party>
  <keyword>Allogene MSCs</keyword>
  <keyword>transplantation</keyword>
  <keyword>chronic liver diseases</keyword>
  <keyword>portal vein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

